Business Line

Novartis cannot block generic version of Entresto, judge rules

A US federal judge rejected Swiss drugmaker Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from selling a generic version of the blockbuster heart medication Entresto. In a ...
Pharmabiz

Lupin receives US FDA approval for sacubitril and valsartan tablets

Global pharma major Lupin Limited (Lupin) announced that it has received United States Food and Drug Administration (FDA) approval for its Abbreviated new Drug Application (ANDA), sacubitril and ...
health.economictimes.indiatimes

Alembic Pharmaceuticals receives US FDA final approval for Sacubitril, Valsartan tablets

Sacubitril and Valsartan tablets are indicated to reduce the risk of cardiovascular death and hospitalisation for heart failure in adult patients with chronic heart failure. It is also indicated for ...
Business Line

Alembic Pharma gains 0.92% on USFDA nod for Sacubitril and Valsartan tablets

https://www.thehindubusinessline.com/markets/alembic-pharma-gains-092-on-usfda-nod-for-sacubitril-and-valsartan-tablets/article68231662.ece Copy Alembic ...